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ABSTRACT
Objectives: To evaluate effectiveness of a structured
one-to-one behaviour change programme on weight
loss in obese and overweight individuals.
Design: Randomised controlled trial.
Setting: 23 general practices in Camden, London.
Participants: 381 adults with body mass index
$25 kg/m
2 randomly assigned to intervention
(n¼191) or control (n¼190) group.
Interventions: A structured one-to-one programme,
delivered over 14 visits during 12 months by trained
advisors in three primary care centres compared with
usual care in general practice.
Outcome measures: Changes in weight, per cent
body fat, waist circumference, blood pressure
and heart rate between baseline and 12 months.
Results: 217/381 (57.0%) participants were
assessed at 12 months: missing values were
imputed. The difference in mean weight change
between the intervention and control groups was not
statistically signiﬁcant (0.70 kg (0.67 to 2.17,
p¼0.35)), although a higher proportion of the
intervention group (32.7%) than the control group
(20.4%) lost 5% or more of their baseline weight
(OR: 1.80 (1.02 to 3.18, p¼0.04)). The intervention
group achieved a lower mean heart rate (mean
difference 3.68 beats per minute (0.31 to 7.04,
p¼0.03)) than the control group. Participants in the
intervention group reported higher satisfaction and
more positive experiences of their care compared
with the control group.
Conclusions: Although there is no signiﬁcant
difference in mean weight loss between the
intervention and control groups, trained non-specialist
advisors can deliver a structured programme
and achieve clinically beneﬁcial weight loss in some
patients in primary care. The intervention group
also reported a higher level of satisfaction with the
support received. Primary care interventions are
unlikely to be sufﬁcient to tackle the obesity epidemic
and effective population-wide measures are also
necessary.
Clinical trial registration number: Trial
registrationClincaltrials.gov NCT00891943.
INTRODUCTION
Overweight and obesity are major public
health problems,
1 representing the ﬁfth
leading cause of death in the world
2 and an
increasing global challenge.
3 Obesity has
severe impacts on health, increasing the risk
of type 2 diabetes, hypertension, some
cancers, heart and liver disease.
145The
Foresight Report
6 estimated the National
Health Service costs attributable to obesity in
2007 as £4.2 billion. In 2010, 68% of men and
58% of women in England were overweight or
obese (body mass index (BMI) $25 kg/m
2).
7
Obesity is a chronic condition requiring
lifelong management as weight loss is often
regained.
8 9 Achieving changes in behaviour is
challenging,
10 largely due to an inability to
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ARTICLE SUMMARY
Article focus
- Evaluated structured one-to-one weight manage-
ment programme.
- Delivery by trained non-specialists.
- Primary care setting.
Key messages
- Clinically important level of weight loss achieved
by higher proportion of participants in the
intervention (33%) compared with the control
group (20%).
- Intervention group reported higher level of
satisfaction with support received.
- Primary care interventions are unlikely to be
sufﬁcient to tackle the obesity epidemic.
Strengths and limitations of this study
- Relatively low threshold of body mass index $25
for inclusion, with few exclusions, so wide
applicability of ﬁndings.
- High loss to follow-up (43%), although similar to
other studies in the area; used multiple imputa-
tion to counter any biases.
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Open Access Researchmaintain healthy eating and physical activity behaviours.
11
Modest weight loss (3%e9%) can prevent type 2 diabetes,
improve fasting plasma glucose, blood pressure and
lipids, and reduce antihypertensive medication.
12e16 Most
overweight patients would like help with weight manage-
ment from their general practices,
17 weight loss is feasible
in the short term (3e12 months)
18 19 and estimated to be
cost saving to the NHS,
20 although few recall receiving
weight control advice from a health professional.
21
The aim of this study was to develop and evaluate the
efﬁcacy of an intervention programme with 12-month
follow-up, for an ethnically diverse overweight/obese
population recruited from general practices in a prag-
matic randomised controlled trial (RCT) following the
Medical Research Council framework for complex
interventions.
22 To our knowledge, there are currently
no other published RCTs of one-to-one lifestyle inter-
ventions delivered in UK general practice to overweight/
obese patients without comorbidities.
METHODS
Aims
The aims of the study were to assess, by means of
a pragmatic parallel group RCT, the effects on anthro-
pometric measures, health-related parameters and the
sense of well-being of offering individualised weight
management advice in primary care to overweight/obese
people who wished to lose weight and to identify the key
factors inﬂuencing the outcome of the intervention.
The primary outcome was the difference between the
control and intervention groups in changes in body
weight, and the secondary outcomes were differences in
waist circumference, per cent body fat, blood pressure
and heart rate from baseline to 12 months.
Interventions
The intervention combined evidence-based components
recognised as essential for behaviour change and
successful weight loss
23dhealthier eating, increased
physical activity incorporated into patients’ everyday
lifestyles, tailored goal setting, keeping food and activity
diaries, self-monitoring, positive reinforcement, coping
with lapses and high-risk situations and long-term
supportdderived from theoretical frameworks under-
pinning health promotion that have an emphasis on
long-term changes in habits. This includes, for example,
social cognitive theory,
24 which addresses diet and
activity-related social support, outcome expectations,
self-efﬁcacy and self-regulation as well as diet and phys-
ical activity monitoring to assess changes over time and
goal setting.
25 It also emphasised SMART (Speciﬁc,
Measurable, Attainable, Relevant, Timely) goal setting,
the relationship between goals and satisfaction and the
achievement of goals and rewards, and systems
thinking,
26 which focuses on environmental changes and
stresses long-term changes in routines. The programme
also incorporated NICE guidance on management of
overweight and obesity
27 as well as evidence-based prin-
ciples of behaviour modiﬁcation,
23 adherence to treat-
ment
28 and results from our pilot study (ﬁgure 1).
18 Six
CAMWEL advisors were recruited from various occupa-
tional backgrounds including healthcare, in line with
the NHS health trainers initiative.
35 The advisors
received initial training over 2 days and further meetings
with the research team every 3e4 months. Training of
advisors included brieﬁng on the obesity epidemic; food
and physical activity behaviours associated with excess
weight; principles of best practice and behaviour change
strategies; evidence for what has been shown to work in
weight loss management programmes; the use of moti-
vational interviewing methods, counselling techniques
and cognitiveebehavioural therapy methods to provide
tailored support for behaviour change; together with
details of the study design and role play. All advisors were
given a copy of the National Obesity Forum CD-Rom
‘Managing Obesity in Primary Care’. Participants were
invited to attend 30 min sessions with the advisor every
fortnight for the ﬁrst 12 weeks, every 3 weeks for
12 weeks and ﬁnally monthly for the next 12 weeks,
making a total of 14 sessions. A script and schedule of
topics for discussion were provided to the advisors for
each session. The topics included personally agreed
weight loss goals, eating and physical activity goals,
exploration of motivations for losing weight, personal
cues to reduce unhealthy eating and sedentary behav-
iour, support from family and friends, triggers associated
with habits and routines, long-term beneﬁts of small
changes and the importance of scheduling and time
management. A commercially available weight manage-
ment software package (http://www.perfect-diet-tracker.
com) was used to record and monitor participant prog-
ress and keep notes of each session by the advisors. The
advisors were provided with access to a book giving the
calorie content of foods available in the UK,
33 ak i t
including 100-calorie portions of various food items and
Adams Food and Alcohol Portion Pots (http://www.
adamsportionpot.com). The intervention participants
were given pedometers and handouts associated with
each session, including a tailored motivational booklet
to encourage increased levels of physical activity and
a book of walks in the local area specially prepared for
the study (appendix 1). Further details are available
from the corresponding author (KN).
There is no current comparator ‘gold standard’ treat-
ment programme available for weight management in
general practice. In this pragmatic trial of a complex
intervention, we assess the beneﬁt of the intervention
compared with routine clinical practice. We provided
a copy of the Quick reference NICE clinical guideline on
Obesity to all participating general practitioners (GPs)
27
and asked control participants to contact their general
practice to receive usual weight management care
provided by the practice, which could include referral to
a dietitian (http://www.camden.nhs.uk/adult-weight-
management-service.htm), exercise on referral, the
‘Shape-Up’ programme (http://camden.gov.uk/ccm/
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Randomised controlled trial of the Camden Weight Loss (CAMWEL) programmenavigation/leisure/sport-and-physical-activity/get-active-
and-healthy/lose-weight/), prescription of weight loss
medication, weight loss surgery or no further treatment.
All participants were given the British Heart Founda-
tion booklet: “So you want to lose weight . for good.”
36
Recruitment
All general practices in Camden were visited and invited
to participate in the trial. Participants were recruited
between July 2009 and January 2010 from 23 of 39 NHS
Camden general practices. The London Borough of
Camden has areas of relative afﬂuence alongside areas of
relative deprivation, with approximately 35% of the
population living in areas classiﬁed as some of the most
deprived in England.
37 Education levels are also dispa-
rate, with 47% of people in employment being educated
to degree level or above, while 17% of working age
people have no qualiﬁcations.
38 Camden has an ethni-
cally diverse population, with 27% belonging to minority
ethnic groups.
38
Figure 1 CAMWEL intervention
framework.
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Randomised controlled trial of the Camden Weight Loss (CAMWEL) programmeSeveral recruitment approaches were used. Primarily,
participating practices wrote to a sample of patients with
BMI $25 kg/m
2; GPs and practice nurses were provided
with referral ‘prescription’ pads with a tear-off slip to be
given to the patient with contact details of the trial
ofﬁce; and posters and ﬂyers were placed in practice
waiting areas and local pharmacies. During the ﬁnal
6 weeks of the recruitment period, three practices
supplemented recruitment by sending text messages to
potentially eligible patients using their electronic record
(EMIS) and messaging (iPLATO) systems. All practices
were reimbursed for time spent on recruitment.
Baseline measurements
Potential participants were screened by telephone for
eligibility (MH, EH, TP). Inclusion criteria were: age
18 years and above, BMI $25 kg/m
2, attending
a participating practice and willing to attend visits with
a CAMWEL advisor over 12 months. Exclusion criteria
were pregnancy or lactation, diagnosis of renal failure,
use of a pacemaker, recent diagnosis of cancer or
participation in another weight management study.
Following GP consent, participants were scheduled for
screening appointments with a researcher (MH) at one
of three practices. The study was explained and the
participant invited to give informed written consent and
to complete the baseline questionnaire. Height (without
shoes) was measured to the nearest 0.1 cm using
a stadiometer. Weight (in light clothing) was measured
using the Tanita (BC 420 MA) scales. The scales also
reported per cent body fat, basal metabolic rate and
metabolic age (age expected for a given value of basal
metabolic rate). Waist was measured midway between
the iliac crest and the costal margin to the nearest
0.1 cm. Blood pressure and heart rate were measured
using a digital automatic monitor (Omron Model
M10-IT), with the average of three readings recorded
where possible. The printout from the Tanita scales,
including weight, BMI and metabolic age, was given to
all participants.
Outcomes
All participants were invited for follow-up at 6 and
12 months. A letter was sent 3 weeks prior to the due
date, followed by a telephone call to arrange the
appointment. Three attempts were made to contact each
participant. Measurements taken at baseline were
repeated and participants were asked to complete
a questionnaire. A £30 voucher was provided for their
time to all participants who completed each follow-up
appointment.
The self-completed questionnaires included the
following validated measures: EuroQol Visual Analogue
Scale, Obesity and Weight Loss Quality-of-Life,
39
Hospital Anxiety and Depression Scale,
40 Rosenberg
measure of self-esteem,
41 Duke-UNC Functional Social
Support Questionnaire,
42 Three-Factor Eating Ques-
tionnaire-18
43 and physical activity (RPAQ),
44 as well as
socio-demographic information. Deprivation was ascer-
tained using the Index of Multiple Deprivation based on
the participant’s home address postcode.
45
In addition, at follow-up, we used the Patient Assess-
ment of Care for Chronic Conditions
46 47 to assess the
participants’ views on the care they received from the
advisors and the GP practice on helping them lose
weight. A brief series of statements was used to assess
participants’ conﬁdence in their ability to manage their
weight on a scale of 1 (disagree strongly) to 4 (agree
strongly). Further questions asked about the type of help
received from the GP practice regarding weight loss,
changes made in behaviours related to weight manage-
ment and experience of study participation. Participants
in the intervention group also completed an additional
section to ascertain how helpful they found the sessions
and materials provided as part of the CAMWEL
programme.
Randomisation
Participants were randomly allocated (allocation ratio
1:1) to the control or intervention group (TP, EH, AS),
using a computer-generated randomisation application
written in VBA for MS Access (TP). The Taves method of
minimisation
48 was used to ensure the groups were
balanced for general practice, gender, age group (#50/
>50 years), BMI category (#30/>30 kg/m
2), diagnosis
of diabetes (yes/no) and taking antipsychotic medication
or not.
Blinding
The study was single blinded with members of the study
team assessing baseline and follow-up measurements
blinded to group assignment.
Sample size
In our pilot study, participants had a mean weight of
98.1 kg (SD 17.3 kg) at baseline.
18 Since a loss of 5%e
10% of body weight in obese adults is associated with
signiﬁcant reductions in the risk of obesity comorbid-
ities, we considered a difference in weight between
groups of 7% at 12-month follow-up to be clinically
important. For the sample size calculation, we wished to
detect a mean weight difference of 6.9 kg at 12 months
between the two groups with two-sided statistical signiﬁ-
cance of 1%, power at 90% and the correlation coefﬁ-
cient between baseline and follow-up values
conservatively set at 0.7. We thus calculated a total
sample size of 228 (114 per group). Assuming a loss to
follow-up at 12 months of 40%,
49 it was estimated that
380 participants would be required.
Statistical methods
Comparisons between groups for continuous variables
were performed using two-sample t tests and regression
methods, adjusting for the baseline value of the vari-
able. c
2 tests and logistic regression were used for
categorical variables. Changes were calculated as value
at follow-up minus baseline value. Primary analyses were
conducted on an intention-to-treat basis, using multiple
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up. Exclusion of subjects with missing data is inefﬁcient
and can lead to biased results if those dropped are
atypical in some respect
50 and MI can both increase
efﬁciency and reduce bias in such settings.
51 52 Miss-
ingness in this study is dominated by attrition, but there
are also some intermediate missing outcome values and
missing baseline values (although not for weight) so the
‘Fully Conditional Speciﬁcation’ form of MI has been
used.
53 For each outcome, the full set of imputation
variables comprised the outcomes at each of the three
occasions, together with a set of baseline variables
selected for their non-negligible association with miss-
ingness or weight loss. For all outcomes, the following
baseline variables were included: age, weight, per cent
body fat, BMI, fat mass, metabolic age, deprivation
status and employment status as well as totals from the
Obesity and Weight Loss Quality-of-Life, EuroQol Visual
Analogue Scale, Hospital Anxiety and Depression Scale
anxiety, Three-Factor Eating Questionnaire emotional
eating and RPAQ scales. The imputation procedure was
carried out separately for the two groups (intervention
and control), and the resulting multiply imputed data
sets were combined for the ﬁnal MI analysis. A total of
200 imputations were used to stabilise the results and to
ensure negligible loss of power.
50 Analyses using only
data on participants who completed 12-month follow-up
were also conducted.
Exploratory analyses (not using MI) were conducted
excluding subjects who had bariatric surgery or were
prescribed weight loss medication during the course of
the trial. We also examined whether the degree of weight
loss was associated with baseline characteristics or with
changes in health or quality-of-life measures. Analyses
were performed using STATA V.11.
Ethical approval
The study was approved by the London School of
Hygiene & Tropical Medicine Ethics Committee, the
Camden and Islington Community Research Ethics
Committee (reference number 09/H0722/22) and the
North Central London Research Consortium.
Figure 2 Flow of participants
through the trial.
Randomised
Follow-up
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Randomised controlled trial of the Camden Weight Loss (CAMWEL) programmeRESULTS
Participants were followed up at 6 months between
January 2010 and July 2010 and at 12 months between
July 2010 and January 2011. Participant ﬂow through the
trial is shown in ﬁgure 2.
Baseline characteristics
We recruited 381 participants with a median age of 48.5
(IQR 37.5e60.4), weighing 60.1e152.2 kg, with waist
circumference of 76e147 cm. The majority (72%) were
women, 12% (47/381) had diagnosed diabetes, 1.3%
(5/381) were on antipsychotic medication, 60% were in
employment, 47% were university graduates and 73%
described their ethnicity as Caucasian (table 1). Partici-
pants wanted to lose an average of 18 kg (SD ¼12.4),
representing 16.7% of their baseline weight. There were
no signiﬁcant differences between groups for any of
these variables.
Response rates
Measurements were obtained for 69% (n¼263) of the
sample at 6 months and 57% (n¼217) at 12 months.
There were no signiﬁcant differences in follow-up rate at
12 months by randomisation group (60.0% control,
53.9% intervention, p¼0.23), but those followed up
tended to be older, have lower BMI, fat mass and per
cent body fat, and were less likely to be from a deprived
area than those not followed up (table 2).
Table 1 Baseline characteristics of participants wishing to lose weight allocated to usual care (control) or to the CAMWEL
programme (intervention)
Characteristics Control group (n[190) Intervention group (n[191) All (n[381)
Age (years), % (n) 49.35 (15.45) 48.17 (14.09) 48.76 (14.77)
Age group (years), % (n)
18e<35 20.53 (39) 20.94 (40) 20.73 (79)
35e<50 32.63 (62) 31.41 (60) 32.02 (122)
50e<60 19.47 (37) 24.08 (46) 21.78 (83)
$60 27.37 (52) 23.56 (45) 25.46 (97)
Body weight (kg) 90.95 (18.12) 93.70 (18.40) 92.33 (18.29)
Waist circumference (cm) 105.83 (13.01) 107.56 (12.78) 106.70 (12.91)
Per cent body fat 38.90 (7.83) 39.45 (8.06) 39.18 (7.93)
Fat mass (kg) 35.83 (12.82) 37.28 (12.70) 36.52 (12.76)
Muscle mass (kg) 52.18 (10.05) 53.39 (10.55) 52.76 (10.30)
BMI (kg/m
2) 33.02 (5.40) 33.92 (5.64) 33.47 (5.53)
BMI 25e<30, % (n) 31.05 (59) 25.65 (49) 28.35 (108)
BMI $30, % (n) 68.95 (131) 74.35 (142) 71.65 (273)
Systolic blood pressure (mm Hg) 126.42 (20.44) 127.43 (20.17) 126.92 (20.28)
Diastolic blood pressure (mm Hg) 82.15 (12.36) 83.40 (12.83) 82.77 (12.59)
Heart rate (beats per minute) 76.68 (12.05) 75.94 (12.03) 76.32 (12.03)
Demographic details, % (n)
Gender: Female 72.63 (138) 71.73 (137) 72.18 (275)
Ethnicity: white 70.63 (101) 74.25 (124) 72.58 (225)
Education
No qualiﬁcations 14.19 (21) 8.82 (15) 11.32 (36)
O/A-level or equivalent 27.71 (41) 38.23 (65) 33.33 (106)
University degree 48.65 (72) 44.71 (76) 46.54 (148)
Employment
Employed fulltime 37.50 (57) 49.12 (84) 43.65 (141)
Employed half-time 19.08 (29) 14.04 (24) 16.41 (53)
Unemployed 43.42 (66) 36.84 (63) 39.94 (129)
Area deprivation (IMD)
Lowest quartile (deprived) 26.06 (49) 23.94 (45) 25.00 (94)
2nd quartile 25.00 (48) 23.40 (44) 24.20 (91)
3rd quartile 25.53 (47) 25.00 (47) 25.27 (95)
Highest quartile (afﬂuent) 23.40 (44) 27.66 (52) 25.53 (96)
Family member overweight 78.67 (118) 77.33 (133) 77.95 (251)
Qol (range of values for each scale)
EQ-VAS (0, 100) 48.22 (30.18) 47.42 (30.68) 47.80 (30.40)
Self-esteem (1, 30) 18.51 (6.01) 18.95 (5.89) 18.74 (5.94)
Social support (1, 5) 3.84 (1.03) 3.91 (1.02) 3.87 (1.03)
Depression (0, 19) 6.07 (4.20) 6.34 (4.31) 6.21 (4.25)
Anxiety (0, 19) 7.81 (4.32) 8.66 (4.83) 8.25 (4.60)
Obesity-related Qol (0, 102) 51.29 (26.71) 48.55 (25.47) 49.85 (26.06)
Values are means (SDs) unless stated otherwise (number of subjects may differ for each variable).
BMI, body mass index; EQ-VAS, EuroQol Visual Analogue Scale; IMD, Index of Multiple Deprivation; Qol, quality of life.
6 Nanchahal K, Power T, Holdsworth E, et al. BMJ Open 2012;2:e000793. doi:10.1136/bmjopen-2011-000793
Randomised controlled trial of the Camden Weight Loss (CAMWEL) programmePrimary outcome
Based on the intention-to-treat analysis using imputed
missing values (table 3), at 12-month follow-up, struc-
tured support resulted in a mean difference in weight
loss between the two groups of  0.70 ( 2.71 to 0.76) kg.
A higher proportion of participants lost 5% or more of
their baseline weight in the intervention (32.7%, 95% CI
24.9% to 40.5%) when compared with the usual care
(20.4%, 95% CI 13.3% to 27.5%) group (OR 1.80 (1.02
to 3.18, p¼0.04).
Secondary outcomes
The intervention programme was also associated with
weak evidence of beneﬁcial trends in waist circumfer-
ence, per cent body fat and per cent weight change.
Heart rate was reduced by 3.7 (0.3 to 7.0, p¼0.03) beats
per minute in the intervention group compared with the
control group.
Based on data for participants who completed the 12-
month follow-up (table 3), a higher proportion (one in
three compared to one in ﬁve) in the intervention group
had lost at least 5% of their initial weight (difference
14.7% (3.0 to 26.4, p¼0.01)) and experienced a greater
average reduction in waist circumference (difference
1.88 cm (0.01 to 3.76, p¼0.05)) compared with those in
the control group. Weak evidence of reductions in weight,
per cent body fat, BMI, blood pressure and heart rate
were observed in the intervention group compared with
the control group. The absolute risk reduction for losing
5% baseline weight was 14.7% (3.0 to 26.4), and the
number needed to treat was 6.8 (3.8 to 33.2). A higher
proportion of those in the intervention group (84%, 21/
25) who had lost $5% at 6 months had managed to keep
this level of weight loss at 12 months compared with those
in the control group (61.5%, 8/13). We were unable to
identify characteristics of the subgroup of participants
more likely to lose 5% of their baseline weight.
No evidence of differences was found between the two
groups on any of the psychological or quality-of-life
measures.
Trial participation
Participants in the intervention group were more satis-
ﬁed than those in the control group with the level of
weight loss achieved and they found participation in the
trial and feedback of physical measurements helpful
(table 4). The intervention group also reported
receiving more patient-centred care than those in the
control group as measured by the Patient Assessment of
Care for Chronic Conditions scales (table 5). Detailed
analysis of the interviews and focus groups with a subset
of the participants will be reported elsewhere.
The intervention programme
The majority of participants (38/56, 67.9%) reported
that a regular meeting with the advisor was the most
helpful aspect of the programme and the least helpful
was the use of handouts in improving eating habits (17/
56, 30.3%). The majority (84%) said they would choose
to continue to meet an advisor beyond the 12 months of
Table 2 Comparison of baseline characteristics of participants followed up at 12 months and those lost to follow-up (mean
(SE) unless otherwise stated)
Followed up Lost to follow-up
Difference (lost to follow-
up L followed up)
Mean (95% CI)
Number (%) 217 (57.0) 164 (43.0)
Age (years) 51.22 (1.01) 45.50 (1.10)  5.72 ( 8.68 to  2.77)
Weight (kg) 90.86 (1.19) 94.26 (1.48) 3.39 ( 0.31 to 7.10)
Waist (cm) 106.50 (0.89) 106.96 (0.99)  0.46 ( 2.18 to 3.10)
Per cent body fat 38.47 (0.55) 40.10 (0.60) 1.63 (0.02 to 3.24)
BMI (kg/m
2) 32.92 (0.37) 34.18 (0.44) 1.26 (0.14 to 2.37)
Metabolic age (years) 60.70 (0.98) 56.50 (1.08)  4.20 ( 7.06 to  1.28)
Fat mass (kg) 35.26 (0.93) 38.14 (1.07) 2.88 (0.10 to 5.67)
Muscle mass (kg) 52.49 (0.76) 53.10 (0.86) 0.61 ( 1.65 to 2.87)
Basal metabolic rate (kcal) 1682 (23.17) 1721 (27.23) 39.0 ( 31.0 to 109.0)
Female, % (n) 70.97 (154) 73.78 (121) 2.81 ( 6.23 to 11.86)
Married/cohabiting, % (n) 45.36 (83) 48.00 (60) 2.64 ( 8.70 to 13.99)
White ethnicity, % (n) 73.02 (138) 71.90 (87)  0.11 ( 11.32 to 9.10)
No qualiﬁcations, % (n) 13.16 (25) 8.59 (11)  4.56 ( 11.40 to 2.27)
Employed, % (n) 81.68 (107) 71.90 (87)  9.78 ( 20.17 to 0.61)
Deprived area, % (n) 19.16 (41) 32.72 (53) 13.55 (4.61 to 22.50)
Self-esteem 19.14 (0.44) 18.15 (0.55)  0.99 ( 2.38 to 0.40)
Social support 3.86 (0.08) 3.91 (0.09) 0.05 ( 0.18 to 0.29)
Anxiety 4.73 (0.14) 5.13 (0.16) 0.40 ( 0.01 to 0.82)
Depression 3.51 (0.13) 3.68 (0.17) 0.17 ( 0.23 to 0.59)
EQ-VAS 62.44 (1.53) 54.92 (2.31)  7.52 ( 2.05 to 12.98)
Obesity and weight-related quality of life 47.31 (1.89) 53.56 (2.37) 6.25 (0.33 to 12.18)
BMI, body mass index; EQ-VAS, EuroQol Visual Analogue Scale.
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Randomised controlled trial of the Camden Weight Loss (CAMWEL) programmethe current study, with most (73%) preferring to see the
advisor at least every 4 weeks.
Behaviours associated with losing 5% or more of baseline
weight
Participants who lost 5% or more of their baseline
weight were more likely to state that they had reduced
their fat and sugar intake in the previous 6 months than
those who did not; there was no evidence of increasing
levels of physical activity between the groups (table 6).
They also reported that attending regular meetings with
a non-judgemental advisor, discussion on portion sizes
and use of the pedometer were particularly useful and
that they would continue to monitor food intake to
maintain their weight.
Exploratory analysis
Thirty-eight participants were known to have been
prescribed drugs for weight loss or to have undergone
weight loss surgery during the trial period. Of these, 27
were followed up at 12 months (12 control: mean weight
change  2.44 kg ( 7.15 to 2.27); 15 intervention: mean
weight change  3.51 kg ( 6.95 to  0.08)). The difference
between groups was 1.07 kg ( 4.32 to 6.46, p¼0.69). In
analysis excluding these participants, those in the inter-
vention group showed signiﬁcantly greater reductions in
weight (1.72 kg (0.29 to 3.14, p¼0.02)), waist circumfer-
ence (2.52 cm (0.32 to 4.72, p¼0.03)), BMI (0.63 kg/m
2
(0.11 to 1.14, p¼0.02)) and per cent baseline weight loss
(1.94% (0.32 to 3.56, p¼0.02)) when compared with the
control group at 12 months. In addition, a higher
Table 4 Participant satisfaction with care received by allocation group at 12 months
Intervention Control
Difference between groups
(intervention L control)
n/N % (SE) n/N % (SE) % (95% CI) p Value
Satisﬁed with level of weight
loss achieved
37/60 61.7 (6.3) 14/61 23.0 (5.4) 38.7 (22.5 to 54.9) <0.0001
Found participating in
CAMWEL helpful in meeting
goals
51/59 86.4 (4.4) 27/60 45.0 (6.4) 41.4 (26.1 to 56.8) <0.0001
Found getting feedback on
physical measurements at
baseline and 6 months helpful
39/58 67.2 (6.3) 20/57 35.1 (6.3) 32.2 (14.9 to 49.5) <0.0001
Found British Heart
Foundation booklet
31 helpful
50/58 86.2 (4.5) 38/53 71.7 (6.2) 14.5 (0.0 to 29.5) 0.06
Table 5 Participant assessment of care received by allocation group at 12 months
Intervention Control
Difference between groups
(intervention L control)
n Mean (SE) n Mean (SE) Mean (95% CI) p Value
PACIC*
Patient activation 58 3.29 (0.17) 56 1.46 (0.13) 1.83 (1.40 to 2.26) <0.0001
Asked for my ideas
Given choices
Asked about any problems
Delivery system design/decision support 58 3.79 (0.14) 55 1.70 (0.16) 2.09 (1.68 to 2.50) <0.0001
Written list of things to do
Care well organised
How what I do inﬂuences weight
Goal setting 58 3.35 (0.13) 54 1.64 (0.14) 1.71 (1.32 to 2.09) <0.0001
Asked to talk about my goals
Helped to set speciﬁc goals
Given copy of my weight loss plan
Encouraged to attend sessions
Asked questions about health habits
Problem solving/contextual counselling 58 3.34 (0.16) 56 1.66 (0.15) 1.69 (1.26 to 2.12) <0.0001
Thought about my beliefs and
traditions when making recommendations
Helped to make plan for my daily life
Plan ahead even for difﬁcult circumstances
Asked how weight affected me
*Patient Assessment of Care for Chronic Conditions (PACIC) score.
46 47
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Randomised controlled trial of the Camden Weight Loss (CAMWEL) programmeproportion of participants in the advisor group lost $5%
of their baseline weight when compared with the control
group (OR 2.68 (1.13 to 5.70, p¼0.03)).
The number of sessions attended was available for 87
participants of whom 40 (46%) attended more than 70%
(10/14) of the available sessions. Half (50%) of the
participants attending more than 70% of the
programme lost 5% or more of their baseline weight
compared with a quarter (23%) who attended fewer
sessions (difference 26.5%, 95% CI 6.9 to 46.3, p¼0.01).
DISCUSSION
Principal ﬁndings
The structured one-to-one weight loss programme deliv-
ered by non-specialists in general practice did not achieve
the pre-speciﬁed difference in average weight loss of 7%.
However, it did result in a higher proportion of the
participants losing 5% or more of their baseline weight
compared with those randomised to usual care, which is
considered a clinically important outcome in similar
trials. This suggests that people likely to beneﬁt from
such a programme are a subset of the total study popu-
lation but we were unable to identify particular charac-
teristics that would permit identiﬁcation of a receptive
group in advance. There was some evidence that the
intervention group experienced greater reductions in
mean weight, waist circumference and % body weight
than the control group. While the overall effects on
weight loss are modest, they are not unimportant.
Strengths and weaknesses of the study
The key strengths of the CAMWEL programme are its
wide applicability to overweight and obese people from
diverse backgrounds as there were few exclusions, feasi-
bility of its delivery in primary care by non-specialist
trained advisors and a patient-centred approach to
making sustainable changes to diet and physical activity
easily incorporated into peoples’ daily lives.
Limitations include the slow initial recruitment,
although this improved over time, particularly with
mobile phone text message use.
54 Loss to follow-up was
high (43%), although similar to that of other weight loss
studies in the UK.
55e58 The response rate in the
DESMOND diabetes management trial
19 was substan-
tially higher (91%), perhaps because participants were
recently diagnosed diabetics and therefore highly moti-
vated. High attrition in RCTs of weight loss is well
recognised,
59 with a recent review reporting losses to
follow-up of 30%e60%.
49
We used MI for missing values to counter any biases
due to loss to follow-up as high level of attrition involves
considerable uncertainty about outcomes for partici-
pants lost to follow-up. We included patients with BMI
$25 as NICE recommends treatment at this level,
although this relatively low threshold and broad inclu-
sion criteria may have diluted the results in terms of
average weight loss thus needing a larger sample to
detect signiﬁcant differences.
Participants in the control group were advised to
contact their general practice to receive the usual care
provided for weight loss. We provided all GPs with NICE
guidelines on obesity and participants with the British
Heart Foundation booklet on weight loss as well as feed-
back on the measurements taken at 6 months. This
provision of support could be one reason why participants
in the control group also lost weight over the period of
Table 6 Reported changes* in eating and activity habits by participants who lost 5% or more of baseline weight compared with
those who did not
Lost 5% or more of
baseline weight
Difference between
groups (yes L no)
Yes
(N[41)
No
(N[111)
n % n % Percent (95% CI) p Value
What changes have you made to your diet during the last 12 months? (Tick all that apply)
Reduced my fat intake 35 85.4 66 59.5 25.9 (11.7 to 40.1) 0.003
Reduced my sugar intake 24 58.5 43 38.7 19.8 (22.0 to 37.4) 0.029
Reduced my portion sizes 28 68.3 58 52.3 16.0 ( 0.97 to 33.0) 0.077
What changes have you made to your activity levels in the last 12 months? (Tick all that apply)
Used the stairs instead of taking the lift 17 41.5 31 27.9 13.6 ( 3.7 to 30.8) 0.111
Joined a gym speciﬁcally to lose weight 13 31.7 20 18.0 13.7 ( 2.2 to 29.6) 0.069
Get off one stop earlier when travelling by bus or tube 8 19.5 16 14.4 5.1 ( 8.7 to 8.9) 0.444
Walk rather than take car for journeys that are less
than one mile
21 51.2 44 39.6 11.6 ( 6.2 to 29.4) 0.200
How will you continue to manage your weight; will you
Monitor your food intake? 32 78.1 59 52.7 25.4 (9.69 to 41.1) 0.005
Control your portions? 26 63.4 59 52.7 10.7 ( 6.67 to 28.1) 0.237
Use a pedometer? 13 31.7 20 17.9 13.8 ( 2.1 to 29.8) 0.065
Monitor your activity patterns? 23 56.1 44 39.3 16.8 ( 0.86 to 34.4) 0.063
*Data are missing for 75 participants who did not complete this section of the questionnaire.
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Randomised controlled trial of the Camden Weight Loss (CAMWEL) programmethe trial resulting in greater similarity of changes in the
two groups, which would represent bias if the GPs altered
their usual care by virtue of trial participation. Outcomes
of RCTs may be inﬂuenced by participants’ treatment
preference
60 and research assessment procedures
61 trig-
gering behaviour change and contributing to the weight
loss seen in the control group.
Behaviour change interventions tend to be complex
with multiple components and it is difﬁcult to assess the
effectiveness of different components. This was a prag-
matic trial reﬂecting the likely performance of the
programme as delivered in practice. While the ﬁdelity of
the delivery of the intervention could be examined in
more detail, we have shown that patient assessment of
the structured support by trained advisors is signiﬁcantly
better than usual care.
Cost-effectiveness analyses are required to inform
decision making about the value of attaining these
outcomes and will be reported in a separate paper.
Putting the study in context
Seven studies of weight change conducted in UK general
practice have been published (see table 7). With the
exception of a trial in newly diagnosed diabetics,
RCTs provided no strong evidence of differences in weight
loss between the intervention and control groups, except
for those using a commercial provider (Weight Watchers).
Our trial achieved results at least comparable with the
more targeted interventions based in general practice.
Implications
We have demonstrated that one-to-one structured support
by a trained advisor in general practice can help people
wishing to lose weight change their behaviour sufﬁciently
leading to a clinically important loss in weight. While
1 year may be too short a time to see all the beneﬁts of
a weight management intervention, the majority of
participants found the Camwel programme helpful
suggesting that they will continue to accrue beneﬁt as they
implement the behaviour change techniques learned
during the study. Understanding how the intervention
worked and why it worked just for some participants as
well as its cost-effectiveness are important and we will
explore these in our subsequent research. The impor-
tance of our results lies in their generalisability. Our
results, together with those from other researchers,
suggest that individual approaches in general practice can
achieve modest beneﬁts for the National Health Service.
However, primary care interventions are unlikely to be
sufﬁcient to address the obesity epidemic and effective
population-wide policy measures are needed as well,
including increasing energy expenditure through active
travel
64 and reducing dietary intake.
Acknowledgements We thank the study participants; the GPs and practice
managers at the participating practices (Abbey Medical Centre, Ampthill
Square Medical Centre, Belsize Priory Medical Practice, The Bloomsbury
Surgery, Brondesbury Medical Centre, Brunswick Medical Centre, Camden
Road Surgery, Chomley Gardens Surgery, Fortune Green Road Surgery,
Gower Place Practice, Gower Street Practice, Grays Inn Medical Centre,
Hampstead Group Practice, James Wigg Group Practice, Kings Cross Road
Practice, Museum Practice, Park End Surgery, Parliament Hill Surgery,
Prince of Wales Group Practice, Swiss Cottage Surgery, Regents Park
Practice); members of the advisory board (Chris Bonell, Phil Edwards, Susan
Jebb, David Simpson and Paul Wilkinson); the advisors (Rosalind Bose,
Gloria Ferenando, Gillian Lampert, Tim Whelan, Gina Williams, Diana
Villamil); as well as Nick Cavill for helping to write the motivational physical
activity handbook, Jim McCambridge for help with training advisors and
commenting on the manuscript, Kate Lees for help with dietary aspects,
Katie Williams (NHS Camden), Suzanne Taylor for data entry, David Taylor
for assistance with database management, Ray Bird for audio-visual
assistance, Laura Doubleday and Sarah Milton for helping with follow-up of
participants, and Adams Portion Pots (Adams Insight Consulting, http://
www.adamsportionpot.com) and NHS Camden for their support of this
study.
Contributors KN, JLT, NT, DH, AK, SE and AH contributed to conception and
design. MH, JLT, KN, EH, AS and UG contributed to acquisition of data, KN,
TP, EH, MK and AH contributed to analysis and interpretation of data, and KN
drafted the article. KN, JLT and AH revised it critically for important intellectual
content. All authors contributed to the ﬁnal approval of the version to be
published.
Funding This work was supported by Camden Primary Care Trust (NHS
Camden). The funding source had no role in the design or conduct of the
study; collection, management, analysis or interpretation of the data and
preparation, review or approval of the manuscript.
Competing interests All authors have completed the Uniﬁed Competing
Interest form at http://www.icmje.org/coi_disclosure.pdf (available on request
from the corresponding author) and declare that KN, TP, EH, MH, AS, UG and
JLT had salary support from NHS Camden for the submitted work. AK was
Director of Public Health at Camden Primary Care Trust between 2004 and
2009. The views expressed here are personal, and no ﬁnancial support was
received for the other authors’ involvement in the CAMWEL Trial. No authors
have had a relationship with companies that might have an interest in the
submitted work in the previous 3 years nor do their spouses, partners or
children have ﬁnancial relationships that may be relevant to the submitted
work. DH is on the scientiﬁc advisory board for LighterLife and no other
authors have non-ﬁnancial interests that may be relevant to the submitted
work.
Ethics approval Ethics approval was provided by the London School of
Hygiene & Tropical Medicine Ethics Committee, the Camden and Islington
Community Research Ethics Committee (reference number 09/H0722/22) and
the North Central London Research Consortium.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement No additional data available.
REFERENCES
1. Whitlock G, Lewington S, Sherliker P, et al; Prospective Studies
Collaboration. Body-mass index and cause-speciﬁc mortality in
900,000 adults: collaborative analyses of 57 prospective studies.
Lancet 2009;373:1083e96.
2. Global Health Risks. Mortality and Burden of Diseases Attributable to
Selected Major Risks. Geneva: World Health Orgainisation, 2009.
3. Finucane MM, Stevens GA, Cowan MJ, et al; Global Burden of
Metabolic Risk Factors of Chronic Diseases Collaborating Group
(Body Mass Index). National, regional, and global trends in body-
mass index since 1980: systematic analysis of health examination
surveys and epidemiological studies with 960 country-years and
9.1 million participants. Lancet 2011;377:557e67.
4. Whitlock G, Lewington S, Mhurchu CN. Coronary heart disease and
body mass index: a systematic review of the evidence from larger
prospective cohort studies. Semin Vasc Med 2002;2:369e81.
5. Haslam DW, James WP. Obesity. Lancet 2005;366:1197e209.
6. Foresight. Tackling Obesities: Future Choices. London: Government
Ofﬁce for Science, 2007.
7. The NHS Information Centre, lifestyles Statistics. Statistics On
Obesity, Physical Activity and Diet. England. 2012. http://www.ic.nhs.
uk/statistics-and-data-collections/health-and-lifestyles/obesity/
statistics-on-obesity-physical-activity-and-diet-england-2012
(accessed Mar 2012).
8. Perri MG, Limacher MC, Durning PE, et al. Extended-care programs
for weight management in rural communities: the treatment of obesity
in underserved rural settings (TOURS) randomized trial. Arch Intern
Med 2008;168:2347e54.
12 Nanchahal K, Power T, Holdsworth E, et al. BMJ Open 2012;2:e000793. doi:10.1136/bmjopen-2011-000793
Randomised controlled trial of the Camden Weight Loss (CAMWEL) programme9. Perri MG, Sears SF Jr, Clark JE. Strategies for improving
maintenance of weight loss. Toward a continuous care model of
obesity management. Diabetes Care 1993;16:200e9.
10. Kinmonth AL, Wareham NJ, Hardeman W, et al. Efﬁcacy of a theory-
based behavioural intervention to increase physical activity in an
at-risk group in primary care (ProActive UK): a randomised trial.
Lancet 2008;371:41e8.
11. Wing RR, Phelan S. Long-term weight loss maintenance. Am J Clin
Nutr 2005;82(Suppl 1):222Se5.
12. Aucott L, Poobalan A, Smith WC, et al. Weight loss in obese diabetic
and non-diabetic individuals and long-term diabetes outcomesea
systematic review. Diabetes Obes Metab 2004;6:85e94.
13. Poobalan A, Aucott L, Smith WC, Avenell A, et al. Effects of weight
loss in overweight/obese individuals and long-term lipid outcomesea
systematic review. Obes Rev 2004;5:43e50.
14. Avenell A, Broom J, Brown TJ, et al. Systematic review of the long-
term effects and economic consequences of treatments for obesity
and implications for health improvement. Health Technol Assess
2004;8:1e182.
15. Norris SL, Zhang X, Avenell A, et al. Long-term effectiveness of
weight-loss interventions in adults with pre-diabetes: a review. Am J
Prev Med 2005;28:126e39.
16. Norris SL, Zhang X, Avenell A, et al. Long-term effectiveness of
lifestyle and behavioral weight loss interventions in adults with type 2
diabetes: a meta-analysis. Am J Med 2004;117:762e74.
17. Potter MB, Vu JD, Croughan-Minhane M. Weight management: what
patients want from their primary care physicians. J Fam Pract
2001;50:513e18.
18. Nanchahal K, Townsend J, Letley L, et al. Weight-management
interventions in primary care: a pilot randomised controlled trial. Br J
Gen Pract 2009;59:e157e66.
19. Davies MJ, Heller S, Skinner TC, et al; Diabetes Education and Self
Management for Ongoing and Newly Diagnosed Collaborative.
Effectiveness of the diabetes education and self management for
ongoing and newly diagnosed (DESMOND) programme for people
with newly diagnosed type 2 diabetes: cluster randomised controlled
trial. BMJ 2008;336:491e5.
20. Trueman P, Haynes SM, Felicity Lyons G, et al. Long-term cost-
effectiveness of weight management in primary care. Int J Clin Pract
2010;64:775e83.
21. Wardle J, Johnson F. Weight and dieting: examining levels of weight
concern in British adults. Int J Obes Relat Metab Disord
2002;26:1144e9.
22. Campbell M, Fitzpatrick R, Haines A, et al. Framework for design and
evaluation of complex interventions to improve health. BMJ
2000;321:694e6.
23. Jones LR, Wadden RA. State of the science: behavioural treatment of
obesity. Asia Pac J Clin Nutr 2006;15(Suppl 1):30e9.
24. Bandura A. Health promotion by social cognitive means. Health Educ
Behav 2004;31:143e64.
25. Locke EA, Latham GP. Building a practically useful theory of goal
setting and task motivation: a 35-year odyssey. Am Psychol
2002;57:705e17.
26. Alemi F, Neuhauser D, Ardito S, et al. Continuous self-improvement:
systems thinking in a personal context. Jt Comm J Qual Improv
2000;26:74e86.
27. NICE Clinical Guidance 43 Obesity: Quick Reference Guide 2 for the
NHS. London: National Institute for Health and Clinical Excellence,
2006.
28. Koenigsberg MR, Bartlett D, Cramer JS. Facilitating treatment
adherence with lifestyle changes in diabetes. Am Fam Physician
2004;69:309e16.
29. Abraham C, Michie S. A taxonomy of behavior change techniques
used in interventions. Health Psychol 2008;27:379e87.
30. Miller WR, Rose GS. Toward a theory of motivational interviewing.
Am Psychol 2009;64:527e37.
31. Foreyt JP, Poston WS. What is the role of cognitive-behavior therapy
in patient management? Obes Res 1998;6(Suppl 1):18Se22.
32. Managing Obesity in Primary Care CD-ROM. National obesity Forum,
2004. nationalobesityforum.org.uk
33. Kellow J, Costain L, Walton R. The Calorie, Carb and Fat Bible.
Peterborough: weight loss Resources, 2009.
34. Byoni Ltd. Perfect Diet Tracker Software. http://www.perfect-diet-
tracker.com/
35. Michie S, Rumsey N, Fussell A, et al. Improving Health: Changing
Behaviour NHS Health Trainer Handbook. London: Department of
Health, 2008.
36. British Heart Foundation. So You Want to Lose Weight. For Good.
London: British Heart Foundation, 2005.
37. NHS Camden. Annual Report & Accounts 2009/10. Camden Primary
Care Trust, 2010. http://www.camden.nhs.uk/downloads/
012522A1_CNHS_Annual%20Report_LR.pdf
38. Forward Planning Service London Borough of Camden Camden Proﬁle
2010. London Borough of camden Forward Planning service. http://
www.camdendata.info/AddDocuments1/Forms/DispForm.aspx?ID¼131
39. Patrick DL, Bushnell DM, Rothman M. Performance of two self-report
measures for evaluating obesity and weight loss. Obes Res
2004;12:48e57.
40. Olssøn I, Mykletun A, Dahl AA. The Hospital Anxiety and
Depression Rating Scale: a cross-sectional study of psychometrics and
case ﬁnding abilities in general practice. BMC Psychiatry 2005;5:46.
41. Rosenberg M. Society and the Adolescent Self Image. Princeton, NJ:
Princeton University Press, 1965.
42. Broadhead WE, Gehlbach SH, de Gruy FV, et al. The Duke-UNC
Functional Social Support Questionnaire: measurement of social
support in family medicine patients. Med Care 1988;26:709e23.
43. Karlsson J, Persson LO, Sjo ¨stro ¨mL ,et al. Psychometric properties
and factor structure of the three-factor eating questionnaire (TFEQ) in
obese men and women. Results from the Swedish obese subjects
(SOS) study. Int J Obes Relat Metab Disord 2000;24:1715e25.
44. Besson H, Brage S, Jakes RW, et al. Estimating physical activity
energy expenditure, sedentary time, and physical activity intensity by
self-report in adults. Am J Clin Nutr 2010;91:106e14.
45. Department for Communities and Local Government. The English
Indices of Deprivation 2010. London. 2010. http://www.communities.
gov.uk/documents/statistics/pdf/1871208.pdf
46. Glasgow RE, Wagner EH, Schaefer J, et al. Development and
validation of the patient assessment of chronic illness care (PACIC).
Med Care 2005;43:436e44.
47. Schmittdiel J, Mosen DM, Glasgow RE, et al. Patient Assessment of
Chronic Illness Care (PACIC) and improved patient-centered
outcomes for chronic conditions. J Gen Intern Med 2008;23:77e80.
48. Scott NW, McPherson GC, Ramsay CR, et al. The method of
minimization for allocation to clinical trials: a review. Control Clin
Trials 2002;23:662e74.
49. Douketis JD, Macie C, Thabane L, et al. Systematic review of long-
term weight loss studies in obese adults: clinical signiﬁcance and
applicability to clinical practice. Int J Obes (Lond) 2005;29:1153e67.
50. Carpenter JR, Kenward MG. Missing Data in Clinical TrialsdA
Practical Guide. National Health Service Coordinating Centre for
Research Methodology. Birmingham. 2008. http://www.haps.bham.
ac.uk/publichealth/methodology/docs/invitations/Final_Report_
RM04_JH17_mk.pdf
51. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New
York: Wiley, 1987.
52. Kenward MG, Carpenter J. Multiple imputation: current perspectives.
Stat Methods Med Res 2007;16:199e218.
53. Royston P. Multiple imputation of missing values. STATA Journal
2004;4:227e41.
54. Nanchahal K, Hession M, Power T, et al. Challenges in recruitment to
clinical trials and lessons learned from a randomized controlled trial of
a weight management intervention in general practice. Obes Rev
2010;11(Suppl S1):P214.
55. McConnon A, Kirk SF, Cockroft JE, et al. The Internet for weight
control in an obese sample: results of a randomised controlled trial.
BMC Health Serv Res 2007;7:206.
56. Counterweight Project Team. Evaluation of the Counterweight
Programme for obesity management in primary care: a starting point
for continuous improvement. Br J Gen Pract 2008;58:548e54.
57. Jebb SA, Ahern AL, Olson AD, et al. Primary care referral to
a commercial provider for weight loss treatment versus standard
care: a randomised controlled trial. Lancet 2011;378:1485e92.
58. Jolly K, Lewis A, Beach J, et al. Comparison of range of commercial
or primary care led weight reduction programmes with minimal
intervention control for weight loss in obesity: Lighten Up randomised
controlled trial. BMJ 2011;343:d6500.
59. Inelmen EM, Toffanello ED, Enzi G, et al. Predictors of drop-out in
overweight and obese outpatients. Int J Obes (Lond) 2005;29:122e8.
60. Thomas E, Croft PR, Paterson SM, et al. What inﬂuences
participants’ treatment preference and can it inﬂuence outcome?
Results from a primary care based randomised trial for shoulder pain.
Br J Gen Pract 2004;54:93e6.
61. McCambridge J, Kypri K. Can simply answering research questions
change behaviour? Systematic review and meta analyses of brief
alcohol intervention trials. PLoS One 2011;6:e23748.
62. Moore H, Summerbell CD, Greenwood DC, et al. Improving
management of obesity in primary care: cluster randomised trial. BMJ
2003;327:1085.
63. Ahern AL, Olson AD, Aston LM, et al. Weight Watchers on prescription:
an observational study of weight change among adults referred to
Weight Watchers by the NHS. BMC Public Health 2011;11:434.
64. Woodcock J, Edwards P, Tonne C, et al. Public health beneﬁts of
strategies to reduce greenhouse-gas emissions: urban land transport.
Lancet 2009;374:1930e43.
Nanchahal K, Power T, Holdsworth E, et al. BMJ Open 2012;2:e000793. doi:10.1136/bmjopen-2011-000793 13
Randomised controlled trial of the Camden Weight Loss (CAMWEL) programmeAPPENDIX 1
The structure of the CAMWEL intervention programme
Session
number Week Topic materials Handouts
1 0 Getting started: establish
working relationship and good
rapport with participant; elicit
personal reasons for losing
weight, build commitment to
program and introduce
lifestyle changes approach.
BHF ‘So you want to lose
weight’ booklet
Sequence of topics Behaviour change diary
Appointment card Food diary
Beneﬁts of healthy habits Activity diary
Recording your routines
Deciding to change
2 2 Changing habits: review
progress, explain importance
of changing habits
permanently and introduce
the ﬁve steps to solving
problems.
Problem solving (Behaviour change diary)
Build a better recipe (Food diary)
Just one more step (Activity diary)
3 4 Healthy eating: review
progress, explain importance
of regular meals, portion
sizes, keeping a record and
discuss making easy food
swaps. (Adam portion pots;
100 kcal portion size food
box)
FSA Eat Well booklet (Activity diary)
Rate your plate
Easy food swaps
Healthy drinks
Food labels card
4 6 Let’s get active: review
progress, explain importance
of activity guidelines and
discuss ways of incorporating
physical activity into
participant’s lifestyle.
Being active Steps chart
Your guide to walking in
Camden
Cut the fat and sugar Printed weight graph
Camden outdoor gyms (Rate your plate)
5 8 Taking charge of your
environment: review
progress, explain importance
of cues and discuss ways of
changing the environment to
make losing weight the ‘easy’
option.
Your environment (Rate your plate)
Goals and rewards (Steps chart)
Eat well on the cheap Printed weight graph
6 10 Eating when out and about:
review progress, explain keys
to making healthy choices
when out and about and
discuss alcohol if appropriate.
Healthy choices (Rate your plate)
Alcohol and your diet (Steps chart)
Eating when out and about
7 12 Tip the calorie balance:
review progress at 3-month
stage of programme; explain
energy balance equation,
importance of healthy eating,
being active, social support
and action planning.
Tipping the calorie balance (Steps chart)
Individual printed weight
graph
(Rate your plate)
8 15 Positive thinking: review
progress and introduce ways
to stop negative thoughts and
‘talk back’ with positive ones.
Positive thinking (Food diary)
Camden Walk4Life maps (Activity diary)
(Steps chart)
(Rate your plate)
(Behaviour change diary)
Continued
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Session
number Week Topic materials Handouts
9 18 Getting off the slippery slope:
review progress, identify
reasons for slips and ways of
getting back on course.
Slippery slope
Camden Walk4Life maps
BHF ‘Healthy meals, Healthy
Heart’ or ‘Food should be fun
and healthy’ menus
Individual printed weight
graph
10 21 Social eating: review
progress, discuss social
settings where it may be
difﬁcult to stay in control of
eating healthily and ways to
overcome this and enjoy
healthy social eating.
Social eating
Individual printed weight
graph
11 27 Staying on course: review
progress, identify successful
changes made and identify
situations where participant
not in control and discuss
ways of overcoming barriers.
Staying on course (Rate your plate)
Healthy snacking (Food diary)
100 Calorie portions (Steps chart)
Meal plansdIndian/minimum
cooking
Individual printed weight
graph
(Activity diary)
12 31 Staying active: review
progress; discuss additional
changes made and how
further activity can be added
into lifestyle.
Staying active (Activity diary)
Individual printed weight
graph
(Steps chart)
13 35 Managing stress: review
progress; discuss how stress
affects weight and ways to
manage stress.
Day-to-day stress (Activity diary)
Individual printed weight
graph
(Steps chart)
(Rate your plate)
(Food diary)
14 47 Reshaping habits: review
progress since start of
programme; discuss ways of
continuing to lose/maintain
changes in the long term.
Reshaping habits (Rate your plate)
Cancer Research UK’s Ten
top tips
(Food diary)
Camden architecture &
walking guide
(Steps chart)
Travel Camden: Camden
walking map
(Activity diary)
Belsize walk; Jubilee Walk
Individual printed weight
graph
Certiﬁcate of achievement
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Nanchahal K, Power T, Holdsworth E, et al. BMJ Open 2012;2:e000793. doi:10.1136/bmjopen-2011-000793 15
Randomised controlled trial of the Camden Weight Loss (CAMWEL) programme